ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms of Astrocytic Activation

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 3400

Special Issue Editor


E-Mail
Guest Editor
Department of Pharmacology, Kobe Pharmaceutical University, Motoyamakita 4-19-1, Higashinada, Kobe 658-8558, Japan
Interests: blood–brain barrier; VCI; astrocyte; brain injury

Special Issue Information

Dear colleagues,

Astrocytes maintain neurotransmission and the trophic support of nerve cells in the normal adult brain, but in many brain disorders, these change phenotype into reactive astrocytes, which is called “astrocytic activation”. Reactive astrocytes are characterized by hypertrophy and high proliferative property, leading to glial scar formation at the site of brain injury. In addition, various kinds of bioactive substances are released from reactive astrocytes. Recent studies have shown that reactive astrocytes and glial scar formation are involved in the pathophysiological responses of damaged brain, including neuroinflammation, brain edema, neurogenesis, neuronal degeneration, and axonal elongation. From these observations, it has been suggested that control of the astrocytic functions can be an effective treatment for the protection of the nervous system and/or the recovery of nerve function from brain disorders. However, the mechanisms underlying astrocytic activation in brain disorders have not been fully clarified, and many researchers are examining signal molecules that induce astrocytic activation.

This Special Issue, “Molecular Mechanisms of Astrocytic Activation”, is designed to collect recent findings on extracellular factors, intracellular signal molecules, and transcriptional factors that underlie the induction of astrocytic activation and the functional alterations. This Issue will welcome original reports, review articles, and commentaries on the molecular mechanisms of astrocyte activation.  In addition, research reports on experiments that attempt to improve brain disorder by utilizing astrocytic function will also be welcome.

Prof. Dr. Yutaka Koyama
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • astrocyte
  • glial scar
  • brain disorders
  • bioactive substances
  • signal transduction
  • transcription factors
  • neuroprotection
  • nerve repair

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 1311 KiB  
Review
Endothelin ETB Receptor-Mediated Astrocytic Activation: Pathological Roles in Brain Disorders
by Yutaka Koyama
Int. J. Mol. Sci. 2021, 22(9), 4333; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22094333 - 21 Apr 2021
Cited by 15 | Viewed by 2898
Abstract
In brain disorders, reactive astrocytes, which are characterized by hypertrophy of the cell body and proliferative properties, are commonly observed. As reactive astrocytes are involved in the pathogenesis of several brain disorders, the control of astrocytic function has been proposed as a therapeutic [...] Read more.
In brain disorders, reactive astrocytes, which are characterized by hypertrophy of the cell body and proliferative properties, are commonly observed. As reactive astrocytes are involved in the pathogenesis of several brain disorders, the control of astrocytic function has been proposed as a therapeutic strategy, and target molecules to effectively control astrocytic functions have been investigated. The production of brain endothelin-1 (ET-1), which increases in brain disorders, is involved in the pathophysiological response of the nervous system. Endothelin B (ETB) receptors are highly expressed in reactive astrocytes and are upregulated by brain injury. Activation of astrocyte ETB receptors promotes the induction of reactive astrocytes. In addition, the production of various astrocyte-derived factors, including neurotrophic factors and vascular permeability regulators, is regulated by ETB receptors. In animal models of Alzheimer’s disease, brain ischemia, neuropathic pain, and traumatic brain injury, ETB-receptor-mediated regulation of astrocytic activation has been reported to improve brain disorders. Therefore, the astrocytic ETB receptor is expected to be a promising drug target to improve several brain disorders. This article reviews the roles of ETB receptors in astrocytic activation and discusses its possible applications in the treatment of brain disorders. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Astrocytic Activation)
Show Figures

Figure 1

Back to TopTop